How much does a box of brigatinib tablets cost on the current market? Detailed price description

Brigatinib (commonly known as brigatinib in China) is a targeted drug used to treat ALK-positive non-small cell lung cancer. The drug has been officially launched in China and has been included in the national medical insurance directory, which has reduced the financial burden on patients. Patients can purchase brigatinib at domestic pharmacies through formal medical channels and enjoy price concessions brought by medical insurance reimbursement.

Currently, the price of brigatinib in the domestic market is about four to five thousand yuan per box. Specific selling prices may vary by region and hospital, and medical insurance reimbursement ratios and policies may also vary. Therefore, patients should consult local hospitals or pharmacies when purchasing drugs to understand the accurate price and reimbursement status. The inclusion of medical insurance has significantly reduced the cost of medication for patients and improved the accessibility of medicines.

In contrast, there are generic versions of brigatinib on the foreign market. The price of the generic drug produced in Laos is relatively low, about a few hundred yuan per box, which is much lower than the domestic original drug. Although they are cheap, the ingredients of these generic drugs are basically the same, and their efficacy and safety are guaranteed, providing some patients with an affordable medication option.

In general, the launch of brigatinib in China and its inclusion in medical insurance has brought real economic convenience to patients with ALK positive lung cancer. Patients can choose the appropriate medication route based on their own financial situation and treatment needs. Whether choosing domestic regular channels or overseas generic drugs, it is recommended that patients use drugs rationally under the guidance of a doctor to ensure the safety and effectiveness of treatment.

Reference materials:https://www.drugs.com